Average Co-Inventor Count = 5.92
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aclaris Therapeutics, Inc. (8 from 20 patents)
2. Pharmacia Corporation (7 from 220 patents)
3. Confluence Life Sciences, Inc. (7 from 12 patents)
4. G.d. Searle & Company (4 from 1,323 patents)
5. Pfizer Corporation (3 from 4,456 patents)
6. Other (1 from 832,912 patents)
7. Adaris Therapeutics, Inc. (1 from 1 patent)
8. Pfizer Products Inc. (47 patents)
31 patents:
1. 12297203 - Pyrrolopyrimidine ITK inhibitors
2. 12281111 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
3. 11820775 - Pyrrolopyrimidine ITK inhibitors
4. 11739086 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
5. 11021482 - Pyrrolopyrimidine ITK inhibitors
6. 10981906 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
7. 10815213 - Bruton's tyrosine kinase inhibitors
8. 10800775 - Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the same
9. 10316038 - Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer
10. 10266513 - Bruton's tyrosine kinase inhibitors
11. 10150783 - Heterocyclic ITK inhibitors for treating inflammation and cancer
12. 9695200 - Heterocyclic ITK inhibitors for treating inflammation and cancer
13. 9636333 - Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
14. 9499551 - Substituted pyrrolo[2,3-b]pyridines for treating cancer or inflammatory diseases
15. 9359300 - Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds